Inventor
Augustine Osuma
Inventor
Lindenhurst, IL, US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes15%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
Y02ATechnologies for adaptation to climate change4%
PatentTitleYear
10,280,184Heterocyclic kinase inhibitors201910,273,238Indazolones as modulators of TNF signaling201910,266,532Tricyclic modulators of TNF signaling201910,160,748Indazolones as modulators of tnf signaling20189,879,016'Indazolones as modulators of TNF signaling'20189,856,253'Tricyclic modulators of TNF signaling'20189,567,339'Primary carboxamides as BTK inhibitors'20179,193,723'NAMPT inhibitors'20159,187,472'NAMPT inhibitors'20158,609,669'Potassium channel modulators'2013Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2013–2019Patents assigned to ABBVIE INC (10)· patent assignee history
2013Patents assigned to BUNNELLE WILLIAM H (1)· patent assignee history
2013Patents assigned to DEGOEY David (1)· patent assignee history
2013Patents assigned to OSUMA AUGUSTINE T (1)· patent assignee history
2013Patents assigned to PATEL JYOTI R (1)· patent assignee history
2013–2019Based in Lindenhurst, IL, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBVIE INC | 10 | 2013–2019 |
| BUNNELLE WILLIAM H | 1 | 2013 |
| DEGOEY David | 1 | 2013 |
| OSUMA AUGUSTINE Tself | 1 | 2013 |
| PATEL JYOTI R | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Lindenhurst, Illinois, US | 10 | 2013–2019 |